epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Blisovi Fe 1.5/ 30
    norethindrone/ ethinyl estradiol
  • remove Elinest
    norgestrel/ ethinyl estradiol
  • remove Histex
    triprolidine
  • remove Kerendia
    finerenone

multicheck MultiCheck Results - 4 Interactions

Smiley face Smiley face

Avoid/Use Alternative

Smiley face Smiley face Blisovi Fe 1.5/30 (norethindrone/ ethinyl estradiol) + Elinest (norgestrel/ ethinyl estradiol)

Avoid/Use Alternative


ethinyl estradiol (contraceptive) + ethinyl estradiol (contraceptive)

avoid combo: combo may incr. risk of HTN, thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, duplicate therapy)

norethindrone (contraceptive) + norgestrel (contraceptive)

avoid combo: combo may incr. risk of thromboembolism, other adverse effects (additive effects, duplicate therapy)

Monitor/Modify Tx

Smiley face Smiley face Blisovi Fe 1.5/30 (norethindrone/ ethinyl estradiol) + Kerendia (finerenone)

Monitor/Modify Tx


ethinyl estradiol (contraceptive) + finerenone

monitor potassium: combo may incr. finerenone levels, risk of hyperkalemia, other adverse effects (hepatic metabolism inhibited)

Smiley face Smiley face Elinest (norgestrel/ ethinyl estradiol) + Kerendia (finerenone)

Monitor/Modify Tx


ethinyl estradiol (contraceptive) + finerenone

monitor potassium: combo may incr. finerenone levels, risk of hyperkalemia, other adverse effects (hepatic metabolism inhibited)

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information